Winchester, MA, United States of America

Gail P Mazzara

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Therion Biologics Corporation, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Bayer Corporation. Active years: 1993-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gail P Mazzara. Retrieved from https://idiyas.com/inventor/gail-p-mazzara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 92.3

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 161(Granted Patents)

Company Filing History:

7 out of 15

Therion Biologics Corporation

patents

4 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Theriod Biologics, Incorporated

patent

Years Active: 1993-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8933041 - System for treating and preventing breast cancer (2015-01-13),

2. 8901093 - Custom vectors for treating and preventing pancreatic cancer (2014-12-02),

3. 7638134 - Insertion sites in fowlpox vectors (2009-12-29),

4. 7410644 - Recombinant pox virus for immunization against tumor-associated antigens (2008-08-12),

5. 6861511 - Detection and quantification of neu related proteins in the biological fluids of humans (2005-03-01),

6. 6051410 - Self-assembled, defective, nonself-propagating viral particles (2000-04-18),

7. 5905040 - Parvovirus empty capsids (1999-05-18),

8. 5804196 - Self assembled, defective, nonself-propagating viral particles (1998-09-08),

9. 5747324 - Self-assembled, defective, non-self-propagating lentivirus particles (1998-05-05),

10. 5736368 - Self assembled defective non-self propagating lentiviral particles (1998-04-07),

11. 5631154 - Self assembled, defective, non-self-propagating lentivirus particles (1997-05-20),

12. 5614404 - Self-assembled, defective, non-self-propagating lentivirus particles (1997-03-25),

13. 5242829 - Recombinant pseudorabies virus (1993-09-07),

Title: Innovator Gail P. Mazzara: Pioneering Cancer Treatment Solutions

Introduction: Gail P. Mazzara, based in Winchester, Massachusetts, is an accomplished inventor with a remarkable portfolio of 13 patents, primarily focused on innovative cancer treatment systems. His work aims to transform the landscape of oncology through cutting-edge biotechnological solutions.

Latest Patents: Among his latest contributions to the field are two significant patents. The first is a "System for Treating and Preventing Breast Cancer," which involves administering a recombinant poxvirus carrying foreign nucleic acid that encodes at least one breast cancer antigen. This novel approach aims to provide a targeted treatment option for individuals at risk of or suffering from breast cancer. The second patent, "Custom Vectors for Treating and Preventing Pancreatic Cancer," also utilizes a recombinant poxvirus, which encodes a pancreatic tumor-associated antigen (PTAA) to combat pancreatic cancer, a disease known for its aggressive nature and low survival rates.

Career Highlights: Gail Mazzara has made substantial contributions to the field of medical research and therapeutics. Notably, he has collaborated with Therion Biologics Corporation and the United States of America, represented by the Secretary of the Department of Health and Human Services. His work emphasizes the integration of biotechnology and therapeutic methods to tackle challenging health issues.

Collaborations: Throughout his career, Mazzara has worked alongside esteemed colleagues such as Dennis L. Panicali and Linda R. Gritz. These collaborations have fostered a dynamic exchange of ideas and innovations that have propelled advancements in cancer treatment methodologies.

Conclusion: Gail P. Mazzara stands out as an influential inventor dedicated to improving cancer treatment options through innovative biotechnological applications. His ongoing work continues to inspire new avenues for research and development in the fight against cancer, demonstrating the power of invention in addressing critical healthcare challenges.

Profile summary based on public USPTO records.